This inventor holds 1 USPTO granted patent and 6 published patent applications and 2 EPO patents. Top assignee: Mesoblast International Sarl. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Michelle Marcelino: Innovator in Stem Cell Research
Introduction
Michelle Marcelino is a prominent inventor based in IJamsville, MD (US). She has made significant contributions to the field of stem cell research, particularly in the development of mesenchymal stem cells that express TNF-α receptors. Her innovative work has the potential to impact treatments for various medical conditions.
Latest Patents
Michelle holds a patent for "Mesenchymal stem cells expressing TNF-α receptors." This patent describes mesenchymal stem cells that express TNF-α receptor Type I in an amount of at least 13 pg/10 cells. These specialized stem cells inhibit the proliferation of lymphocytes and may be employed in the treatment of graft-versus-host disease.
Career Highlights
Throughout her career, Michelle has worked with notable companies, including Mesoblast International Sàrl. Her expertise in stem cell technology has positioned her as a key figure in advancing medical research and therapeutic applications.
Collaborations
Michelle has collaborated with esteemed colleagues such as Alla Danilkovitch and Diane Carter. These partnerships have further enriched her research and contributed to the success of her innovative projects.
Conclusion
Michelle Marcelino's work in stem cell research exemplifies the impact of innovation in medicine. Her contributions continue to pave the way for advancements in treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile